Three Phase 3 Clinical Trials that Could Legalize Psychedelics
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
The road to psychedelic legalization has many paths. These 3 clinical trials have the best chances to legalize psychedelics for therapy
More and more people are turning to psychedelics for healing and insights, even parents. But what does psychedelic parenting look like?
People who smoke DMT describe an intense and profound psychedelic experience, but there’s a trick to getting the most out of each hit
New psychedelic podcasts are popping up every week, but which ones are worth listening to? Here’s a few of our favorites.
Psilocybin mushrooms are rapidly growing in popularity for clinical therapy, research, and recreational use. Here’s your beginner’s guide to these magical fungi
From functional mushroom supplements to psilocybin laced bars, mushroom chocolate is a rapidly growing industry
In a rare move Cybin aquires a phase 1 DMT clinical trial from Entheon Biomedical. CEO Doug Drysdale explains why in a Reddit AMA
A new review finds that the chemical imbalance model of depression is wrong. What lessons can we learn about depression, SSRIs and psychedelics?
This week the DEA announced it would withdraw its plan to schedule 5 research psychedelics. But we shouldn’t celebrate just yet
Project Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian non-profit TheraPsil
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.